Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 60662-14-8
2. Pentetate Indium Disodium In 111
3. 7uit3zgc8e
4. Pentetate Indium Disodium In 111 [usan]
5. Disodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))indate(2-)-(sup 111)in
6. Disodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;indium-111(3+)
7. Pentetate Indium Disodium In 111 (usan)
8. Unii-7uit3zgc8e
9. Indium Dtpa In 111 (tn)
10. Pentetate Indium Disodium In-111
11. Pentetate Indium Disodium,in-111
12. Dtxsid101027591
13. Indium (in111) Disodium Pentetate
14. Pentetate Indium Disodium, In-111
15. D05421
16. Pentetate Indium Disodium,in-111 [vandf]
17. Indium (111 In) Disodium Pentetate [who-dd]
18. Q27268870
19. Indium In-111 Pentetate Disodium [orange Book]
20. Disodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))indate(2-)-111in
21. Indate(2-)-(sup 111)in-, (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, Disodium
Molecular Weight | 545.19 g/mol |
---|---|
Molecular Formula | C14H18InN3Na2O10 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 11 |
Exact Mass | 544.98386 g/mol |
Monoisotopic Mass | 544.98386 g/mol |
Topological Polar Surface Area | 210 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 454 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Related Excipient Companies
ABOUT THIS PAGE
A Pentetate Indium Disodium In 111 Usan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pentetate Indium Disodium In 111 Usan, including repackagers and relabelers. The FDA regulates Pentetate Indium Disodium In 111 Usan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pentetate Indium Disodium In 111 Usan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pentetate Indium Disodium In 111 Usan supplier is an individual or a company that provides Pentetate Indium Disodium In 111 Usan active pharmaceutical ingredient (API) or Pentetate Indium Disodium In 111 Usan finished formulations upon request. The Pentetate Indium Disodium In 111 Usan suppliers may include Pentetate Indium Disodium In 111 Usan API manufacturers, exporters, distributors and traders.
Pentetate Indium Disodium In 111 Usan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pentetate Indium Disodium In 111 Usan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pentetate Indium Disodium In 111 Usan GMP manufacturer or Pentetate Indium Disodium In 111 Usan GMP API supplier for your needs.
A Pentetate Indium Disodium In 111 Usan CoA (Certificate of Analysis) is a formal document that attests to Pentetate Indium Disodium In 111 Usan's compliance with Pentetate Indium Disodium In 111 Usan specifications and serves as a tool for batch-level quality control.
Pentetate Indium Disodium In 111 Usan CoA mostly includes findings from lab analyses of a specific batch. For each Pentetate Indium Disodium In 111 Usan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pentetate Indium Disodium In 111 Usan may be tested according to a variety of international standards, such as European Pharmacopoeia (Pentetate Indium Disodium In 111 Usan EP), Pentetate Indium Disodium In 111 Usan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pentetate Indium Disodium In 111 Usan USP).
LOOKING FOR A SUPPLIER?